Johnson & Johnson today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVYtm ...
Objective This study aimed to determine the characteristics of acute poisoning patients. Design This was a prospective cohort study. Setting The study was conducted for 1 year (1 July 2023 to 30 June ...
Objectives To describe the characteristics of COVID-19 among elite Japanese athletes and their return-to-play (RTP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback